Universal Biosensors, Inc. (ASX:UBIO)

Universal Biosensors Statistics

Total Valuation

ASX:UBIO has a market cap or net worth of AUD 4.17 million. The enterprise value is 5.02 million.

Market Cap	4.17M
Enterprise Value	5.02M

Important Dates

The last earnings date was Thursday, October 30, 2025.

Earnings Date	Oct 30, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+31.15%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	192.31M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.70
PB Ratio	0.59
P/TBV Ratio	0.59
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-0.29
EV / Sales	0.84
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-0.38

Financial Position

The company has a current ratio of 1.90, with a Debt / Equity ratio of 0.43.

Current Ratio	1.90
Quick Ratio	0.69
Debt / Equity	0.43
Debt / EBITDA	n/a
Debt / FCF	-0.23
Interest Coverage	-2,012.23

Financial Efficiency

Return on equity (ROE) is -110.97% and return on invested capital (ROIC) is -65.00%.

Return on Equity (ROE)	-110.97%
Return on Assets (ROA)	-52.10%
Return on Invested Capital (ROIC)	-65.00%
Return on Capital Employed (ROCE)	-186.74%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	78,304
Profits Per Employee	-229,678
Employee Count	76
Asset Turnover	0.25
Inventory Turnover	1.00

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	n/a
200-Day Moving Average	n/a
Relative Strength Index (RSI)	58.68
Average Volume (20 Days)	119,823

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, ASX:UBIO had revenue of AUD 5.95 million and -17.46 million in losses. Loss per share was -0.06.

Revenue	5.95M
Gross Profit	1.59M
Operating Income	-20.00M
Pretax Income	-17.46M
Net Income	-17.46M
EBITDA	-19.34M
EBIT	-20.00M
Loss Per Share	-0.06

Balance Sheet

The company has 2.20 million in cash and 3.05 million in debt, with a net cash position of -847,863.

Cash & Cash Equivalents	2.20M
Total Debt	3.05M
Net Cash	-847,863
Net Cash Per Share	n/a
Equity (Book Value)	7.08M
Book Value Per Share	0.02
Working Capital	3.81M

Cash Flow

In the last 12 months, operating cash flow was -12.97 million and capital expenditures -340,158, giving a free cash flow of -13.31 million.

Operating Cash Flow	-12.97M
Capital Expenditures	-340,158
Depreciation & Amortization	n/a
Net Borrowing	n/a
Free Cash Flow	-13.31M
FCF Per Share	n/a

Margins

Gross margin is 26.73%, with operating and profit margins of -336.03% and -293.32%.

Gross Margin	26.73%
Operating Margin	-336.03%
Pretax Margin	-293.32%
Profit Margin	-293.32%
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ASX:UBIO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-31.15%
Shareholder Yield	n/a
Earnings Yield	-418.30%
FCF Yield	-319.03%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

ASX:UBIO has an Altman Z-Score of -12.99 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-12.99
Piotroski F-Score	2